Abstract

Cerebral malaria (CM) is a severe clinical complication of Plasmodium falciparum malaria infection and is characterized by a high fatality rate and neurological damage. Sequestration of parasite-infected red blood cells in brain microvasculature utilizes host- and parasite-derived adhesion molecules and is an important factor in the development of CM. ICAM-1, an alternatively spliced adhesion molecule, is believed to be critical on endothelial cells for infected red blood cell sequestration in CM. Using ICAM-1 mutant mice, we found that the full-length ICAM-1 isoform is not required for development of murine experimental CM (ECM) and that ECM phenotype varies with the combination of ICAM-1 isoforms expressed. Furthermore, we observed development of ECM in transgenic mice expressing ICAM-1 only on leukocytes, indicating that endothelial cell expression of this adhesion molecule is not required for disease pathogenesis. We propose that ICAM-1-dependent cellular aggregation, independent of ICAM-1 expression on the cerebral microvasculature, contributes to ECM.

Highlights

  • Endothelium-expressed intercellular adhesion molecule-1 (ICAM-1) is considered critical for the development of cerebral malaria (CM)

  • Using ICAM-1 mutant mice, we found that the full-length ICAM-1 isoform is not required for development of murine experimental Cerebral malaria (CM) (ECM) and that ECM phenotype varies with the combination of ICAM-1 isoforms expressed

  • We report the unexpected finding that ICAM-1 expression on central nervous system (CNS) microvasculature is not required for ECM development

Read more

Summary

Introduction

Endothelium-expressed intercellular adhesion molecule-1 (ICAM-1) is considered critical for the development of cerebral malaria (CM). We observed development of ECM in transgenic mice expressing ICAM-1 only on leukocytes, indicating that endothelial cell expression of this adhesion molecule is not required for disease pathogenesis.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call